Loading
Latest filing published 18 Mar 2025 for Zomedica Corp., €496.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Larry C. Heaton II discloses dealings in Zomedica Corp. to SEC (Form 4). We count 9 filings; the first trade dates from 26 May 2023 and the latest from 17 March 2025.
No open-market sale appears; the market trades are 9 purchases worth €96k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. So far in 2025, the count stands at 4 purchases and no sales.
Half of the purchases are above €11k and half below. 8 out of 9 purchases came within 30 days of a purchase by at least one other insider of the same company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
The latest filing, published on 18 March 2025, reports an open-market purchase of €6,335 in Zomedica Corp. The median gap between a trade and its publication by SEC (Form 4) is 1 day. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations